Other languages Orgenesis Inc.

Equities

ORGS

US68619K2042

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
0.527 ^USD	-2.95%		+3.92%	+5.25%

04-16	North American Morning Briefing : Powell Comments, -2-	DJ
04-15	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-15
Germfree and Orgenesis Inc. Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	04-10
Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	11-08
Sector Update: Health Care Stocks Lower in Afternoon Trading	11-08
Orgenesis Prices $1.1 Million Registered Direct Offering	11-08
CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States	23-09-21
Orgenesis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Orgenesis Names Elliot Maltz Chief Financial Officer	23-07-13
Orgenesis Inc. Announces Efrat Assa Kunik to Resign as Chief Development Officer, Effective August 8, 2023	23-07-12
Morgenesis LLC Announces Collaboration Agreement with SCTbio to Expand POCare Sites in the Czech Republic and Enhance Capabilities for the Production of Lentivirus Vectors	23-05-18
Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22
Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22
Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	23-03-21
Orgenesis Signs Memorandum of Understanding to Roll Out Cell, Gene Therapy Mobile Processing Units, Labs Across California	23-03-16
Orgenesis Signs MOU with University of California, Davis to Develop a Collaboration Agreement to Deploy Cell and Gene Therapy Mobile Processing Units and Labs Across California	23-03-16
Orgenesis Closes $3.7 Million Offering; Shares Rise	23-02-27
Sector Update: Health Care Stocks Finishing with Small Rise	23-02-23
Sector Update: Health Care Stocks Narrowly Lower in Recent Trading	23-02-23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Orgenesis Inc.

Equities

ORGS

US68619K2042

Other languages

Filters